Publikationen, an denen er mitarbeitet Anaïs Corma Gómez (21)

2024

  1. An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response

    Journal of Alzheimer's Disease, Vol. 98, Núm. 2, pp. 601-618

  2. Low rate of vaccination and risk of incident hepatitis A among HIV-infected men who have sex with men in Seville, Southern Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 5, pp. 251-256

2023

  1. Burden of significant liver damage in people living with HIV after microelimination of the hepatitis C virus

    Journal of Infection, Vol. 86, Núm. 1, pp. 41-46

  2. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

  3. Hepatic steatosis after switching to integrase inhibitor-based regimens does not parallel short-term weight gain

    AIDS, Vol. 37, Núm. 14, pp. 2259-2262

  4. Poor increase on HAV vaccination coverage among people living with HIV after an immunization-based intervention

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 3, pp. 144-148

  5. Reduced neutralizing antibody response to SARS-CoV-2 vaccine booster dose in people living with HIV with severe immunosuppression

    Journal of medical virology, Vol. 95, Núm. 3, pp. e28602

2022

  1. Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis

    Scientific Reports, Vol. 12, Núm. 1

  2. Incidence of and factors associated with SARS-CoV-2 infection among people living with HIV in Southern Spain after one year of pandemic

    Transboundary and Emerging Diseases, Vol. 69, Núm. 4, pp. e267-e275

  3. Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV

    Clinical Microbiology and Infection

  4. New insights into the genetic etiology of Alzheimer's disease and related dementias

    Nature genetics, Vol. 54, Núm. 4, pp. 412-436

  5. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

  6. Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV

    Clinical Microbiology and Infection, Vol. 28, Núm. 11, pp. 1492-1498

2021

  1. A genome-wide association study on liver stiffness changes during hepatitis c virus infection cure

    Diagnostics, Vol. 11, Núm. 8

  2. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  3. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

    Nature communications, Vol. 12, Núm. 1, pp. 3417

  4. Genomic characterization of host factors related to SARS-CoV-2 infection in people with dementia and control populations: The GR@ACE/DEGESCO study

    Journal of Personalized Medicine, Vol. 11, Núm. 12

2020

  1. High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment

    Scientific Reports, Vol. 10, Núm. 1

  2. Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. A genome-wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study)

    Liver International, Vol. 39, Núm. 10, pp. 1918-1926